Dr Aviral Singh is a Specialist Physician in Nuclear Medicine from Germany, currently working as Clinical Research and Development Manager for Theranostics and Medical Advisor & Monitor for CRO & NMCIS at GenesisCare at the North Shore Health Hub, Sydney.

He pursued clinical training from Germany, Australia, United Kingdom and Ukraine, and is professionally proficient in English, German and Russian languages. He has extensive experience in Theranostics application in clinical oncology acquired at the world-renowned ENETS Center of Excellence, Zentralklinik Bad Berka.

Aviral gained MSc in Nuclear Medicine from King’s College London and is pursuing PhD in Innovative Cancer Diagnostics and Therapy from Maastricht University, Netherlands. 

His awards and recognitions include Keynote lecture on PRRT in NETs at the ‘György Hevesy’ Hungarian Society of Nuclear Medicine 2017, Keynote Lecture on Theranostics of Prostate Cancer at the Portuguese 17th National Congress of Nuclear Medicine, and Guest Faculty / Lecturer for several international medical societies including ESMO, ENETS, ESO, COSA, WFNMB, and WARMTH. He won first place for scientific poster in clinical oncology at SNMMI 2016 and was enlisted in the Leading Physicians of the World 2017 edition of the International Association of HealthCare Professionals.

Aviral is well-published with over 45 peer reviewed scientific papers and is the member of the Topics Editorial Board of the journal Cells.

Since 2018 Aviral is the elected Treasurer and Member of the Executive Board of the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH).